Menu

Ancient Protein Helps E. coli Thwart Viral Attack

When engineered to use a four-billion-year-old version of the protein thioredoxin, the bacteria can stall bacteriophage replication, a new study shows.

May 9, 2017
Ashley Yeager

CDCResurrecting ancient proteins in modern E. coli can protect the bacterium from viral infection, scientists reported today (May 9) in Cell Reports. Researchers from Spain engineered the genetic sequences that code for ancestral forms of the protein thioredoxin—including one that would have existed about 4 billion years ago—and found that not only did the old protein function in the cells, but when these bacteria were exposed to the bacteriophage T7, they fended off viral infection.

“This is an interesting strategy that impedes the propagation of the virus,” biochemist Reinhard Sterner of the University of Regensburg in Germany told The Scientist. “It could be a new mode of viral resistance, which is pretty cool.”

The project got its start from an interest in plants. Specifically, Asunción Delgado and colleagues at the University of Granada knew that proteins in plants that aid viral replication haven’t evolved so much so that they can avoid being hijacked by viruses. So, the team wondered whether a different version of a protein, possibly an ancestral form, could keep an organism alive but prevent viral replication.

Thioredoxin was a good test subject: it is found in all modern organisms and is essential for both hosts and invading viruses. In the new study, Delgago and colleagues studied the genetic sequences of a range of microbial organisms, traced their ancestry, and identified the sequences for ancient thioredoxins, dating from 1.5 billion to 4 billion years ago.

Ancient versions of the thioredoxin protein (green circles) don’t allow viral DNA to replicate, but the more modern versions (red circles) do. DELGADO ET AL.In E. coli, thioredoxin circulates electrons to keep vital chemical reactions going. When the team replaced the modern thioredoxin gene in E. coli with ancient sequences, the resulting proteins too moved electrons around, with varying degrees of success. The oldest version didn’t work as well as the more recent ones; but the fact that it dated back to the origin of life itself and still kept the E. coli alive was surprising, said chemist Jose Sanchez-Ruiz, the paper’s senior author, in an interview.

The team then mixed the altered E. coli with bacteriophage T7, which normally recruits thioredoxin in bacteria for help in DNA replication. “The virus inserted its DNA into the bacterium without any trouble. But, when the virus went to recruit thioredoxin for its own purposes, that was a problem,” Sanchez-Ruiz said. Thioredoxins that were roughly 2.5 billion years and older couldn’t be used by the virus for DNA replication. The team also tried the experiment with the human form of thioredoxin, which prevented the virus from replicating, too.

Swapping a protein essential to both the host organism and the virus infecting that organism could confer viral resistance. The strategy could be applied to boosting plants’ resistance to viruses, Sanchez-Ruiz said.

“A big hurdle [to deploying ancient proteins in crops] that must be overcome is that the parts of the protein that do not interact with the pathogen do evolve, albeit more slowly than the pathogen-associated parts,” wrote Michael Harms, an evolutionary biophysicist at the University of Oregon, in an email to The Scientist. “As a result, ancestral proteins do not necessarily directly replace their modern counter parts.”

Harms explained that in commercial plants, growth rate, taste, color, and a number of other traits are important. An ancestral gene might compromise one of the many desired traits, even though it might protect against infection. “Because of this, I suspect that ancestral proteins may be a starting point for engineering more resistant plants rather than a standalone, turn-key solution.”

A. Delgado et al., “Using resurrected ancestral proviral proteins to engineer virus resistance.” Cell Reports, doi:10.1016/j.celrep.2017.04.037, 2017.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!